Insider Shareholders with Direct Ownership of Bei Gene, Ltd. (BGNE)
This section provides a comprehensive overview of the insiders with direct ownership of Bei Gene, Ltd. (BGNE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BeiGene, Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Amgen Inc
> 10% Shareholder |
30,385,569 | 0 | 18,943,802 $4.29 Billion | 12 |
Sep 10, 2021
Added 0.87%
|
|
Donald W. Glazer
Director |
53,755 | 832,969 | 2,718,464 $616 Million | 10 |
Jun 05, 2024
Added 0.6%
|
|
Aaron Rosenberg
Chief Financial Officer |
230,802 | 0 | 230,802 $52.3 Million | 3 |
Jun 10, 2025
Added 21.62%
|
|
Anthony C Hooper
Director |
64,740 | 0 | 64,740 $14.7 Million | 5 |
May 21, 2025
Added 14.51%
|
|
Corazon (Corsee) D. Sanders
Director |
64,740 | 578 | 57,226 $13 Million | 6 |
May 21, 2025
Added 16.1%
|
|
Margaret Dugan
Director |
56,940 | 0 | 56,940 $12.9 Million | 4 |
May 21, 2025
Added 16.17%
|
|
Alessandro Riva
Director |
56,940 | 0 | 56,940 $12.9 Million | 4 |
May 21, 2025
Added 16.17%
|
|
Thomas Malley
Director |
37,414 | 0 | 46,696 $10.6 Million | 3 |
Jun 15, 2023
Added 21.67%
|
|
Qingqing Yi
Director |
64,740 | 37,414 | 27,326 $6.2 Million | 7 |
Jun 10, 2025
Reduced 52.01%
|
|
Olivier Brandicourt
Director |
27,326 | 0 | 27,326 $6.2 Million | 2 |
May 21, 2025
Added 28.67%
|
|
Shalini Sharp
Director |
19,136 | 0 | 19,136 $4.34 Million | 2 |
May 21, 2025
Added 36.47%
|
| 127,454 | 27,032 | 10,418 $2.36 Million | 3 |
Oct 13, 2020
Reduced 56.47%
|
|
|
Timothy Yung Cheng Chen
Director |
13,800 | 6,000 | 7,800 $1.77 Million | 5 |
Jun 16, 2021
Added 50.0%
|
|
Jingshyh S Su
Director |
7,800 | 0 | 7,800 $1.77 Million | 1 |
Jun 16, 2021
Added 50.0%
|
|
Julia Aijun Wang
Chief Financial Officer |
410,137 | 5,293 | 0 $0 | 15 |
Jul 01, 2024
Reduced 100.0%
|
|
Xiaodong Wang
Director |
862,322 | 2,618,497 | 0 $0 | 40 |
Jun 24, 2025
Reduced 100.0%
|
|
John Oyler
Chief Executive Officer |
10,222,088 | 5,799,735 | 0 $0 | 49 |
Jul 09, 2025
Reduced 100.0%
|
|
Lai Wang
Global Head of R&D |
1,870,999 | 72,764 | 0 $0 | 25 |
Jun 23, 2025
Reduced 100.0%
|
|
Xiaobin Wu
President and COO |
1,102,748 | 237,213 | 0 $0 | 38 |
Jun 23, 2025
Reduced 100.0%
|
|
Jane Huang
CMO, Hematology |
110,822 | 63,574 | 0 $0 | 43 |
Dec 14, 2021
Reduced 100.0%
|
|
Titus B. Ball
Principal Accounting Officer |
54,028 | 271 | 0 $0 | 4 |
Jun 11, 2025
Reduced 100.0%
|
|
Howard Liang
CFO & Chief Strategy Officer |
1,525,200 | 121,482 | 0 $0 | 11 |
Jun 28, 2021
Reduced 100.0%
|
|
Chan Henry Lee
SVP, General Counsel |
250,757 | 6,795 | 0 $0 | 12 |
Jun 16, 2025
Reduced 100.0%
|